Featured CME Programs

Upcoming CME Events

  • Optimizing Treatment Strategies
    Optimizing Treatment Strategies for Localized and Advanced Genitourinary Malignancies

    Join us for this in-person educational program, offered by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education. The program will cover the latest strategies for optimally managing localized and advanced bladder, kidney and prostate cancer presented by the Fox Chase Cancer Center genitourinary oncology team—nationally recognized physicians specializing in urology, radiation therapy, and medical oncology.

    DATE
    Monday, December 11, 2023

    TIMES
    5:45–7:00 pm – Check-in & Reception (Buffet opens at 6:30)
    7:00–9:00 pm – CME & Dinner

    LOCATION
    Philadelphia Marriott Old City
    One Dock Street
    Philadelphia, PA 19106

    Register

     ... Expand

  • San Antonio Breast Cancer
    22nd Annual Highlights of the 2023 San Antonio Breast Cancer Symposium

    Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, this CME is designed to help medical, radiation, and surgical oncologists, gynecologists, radiologists, and primary care physicians translate the data from key presentations from the 2023 San Antonio Breast Cancer Symposium into practice.

    DATE
    Thursday, January 25, 2024

    Register

    Attached Flyer

    TIMES
    5:45–7:00 pm – Check-in & Reception (Buffet opens at 6:30)
    7:00–9:00 pm – CME & Dinner

    LOCATION
    Philadelphia Marriott Old City
    One Dock Street
    Philadelphia, PA 19106

    PROGRAM DIRECTOR

    Angela Jain, MD
    Assistant Professor,
    Department of Hematology/Oncology

  • 23FC112-ARHM
    Save the Date: Registration to Open in 2024 Atlantic Regional Hematopathology Meeting

    Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, this in-person education program is designed to focus on the role of molecular pathology and new technologies in diagnosis, prognostic stratification, and treatment of complex cases. Participants will gain insights into the significant changes, updates, and new categories in the 5th Edition of the World Health Organization Classification of Hematolympoid Tumors. Renowned invited pathologists and senior authors of the new WHO edition-Dr. Joseph Khoury, Dr. German Ott, and Dr. Sanam Loghavi-will discuss notable updates, modications, and new classifications in the morphology and molecular genetics of hematologic neoplasms that can be immediately applied in practice. As usual, there will be case-based podium presentations followed by discussion. A poster session will also take place.

    DATE
    Saturday, May 11, 2024

    TIMES
    8:30 am- 4pm

    PROGRAM DIRECTOR

    Reza Nejati, MD
    Associate Professor
    Medical Director of TUHS-FCCC Clinical Laboratories
    Director, Flow Cytometry Lab
    Department of Pathology
    Fox Chase Cancer Center

    KEYNOTE SPEAKERS

    Joseph Khoury, MD
    Professor and Head
    Department of Pathology and Microbiology
    University of Nebraska Medical Center

    German Ott, MD
    Professor & Chair,
    Department of Clinical Pathology
    Robert-Bosch Krankenhaus
    Stuttgart, Germany

    DISTINGUISHED GUEST SPEAKER

    Sanam Loghavi, MD
    Associate Professor
    Department of Hematopathology
    MD Anderson Cancer Center

    Inquiries

    Lucía Tono, PhD, MEd: 215-728-3797
    [email protected]

    Intended Audience

    Hematopathologists, pathologists of other subspecialties, hematologists/oncologists, radiation oncologists, internists, primary care providers, fellows and residents of pathology, oncology and other specialties.

    Accreditation Statement

    The Temple Health Office for Continuing Medical Education is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.

    Designation Statement

    The Temple Health Office for Continuing Medical Education designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the educational activity.

Disclosure Policy

It is the policy of the Temple Health Office for Continuing Medical Education to ensure that all sponsored continuing medical education activities are independently designed and produced and include content that is valid, objective, balanced, free of commercial bias and in the best interest to the public. Temple Health policy requires everyone in a position to control the content of an educational activity to disclose all financial relationships with ineligible companies and to disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). The Temple Health Office for Continuing Medical Education has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to the activity.